What is he best known for?
The fields of study he is best known for:
- Bacteria
- Enzyme
- Antibiotics
His primary areas of study are Microbiology, Antibacterial agent, Escherichia coli, Staphylococcus aureus and Norfloxacin.
His Microbiology study combines topics in areas such as Pseudomonas aeruginosa and Bacteria.
His biological study spans a wide range of topics, including Enterobacteriaceae, Sparfloxacin and DNA gyrase.
His Escherichia coli research integrates issues from Streptomycin and Transduction.
His studies deal with areas such as Nalidixic acid and Minimum inhibitory concentration as well as Norfloxacin.
His work deals with themes such as Tetracycline, Oleandomycin, Enteric bacteria and Virology, which intersect with Drug resistance.
His most cited work include:
- Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. (719 citations)
- Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli. (193 citations)
- Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa. (152 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Microbiology, Escherichia coli, Drug resistance, Biochemistry and Antibiotics.
His work carried out in the field of Microbiology brings together such families of science as Plasmid, Virology and Pseudomonas aeruginosa, Staphylococcus aureus, Bacteria.
The various areas that Susumu Mitsuhashi examines in his Virology study include In vitro, Salmonella enteritidis and Immunity.
Susumu Mitsuhashi works mostly in the field of Escherichia coli, limiting it down to concerns involving Molecular biology and, occasionally, Mutant.
His study in Drug resistance is interdisciplinary in nature, drawing from both Tetracycline, Enteric bacteria and Chloramphenicol.
As part of the same scientific family, Susumu Mitsuhashi usually focuses on Antibiotics, concentrating on Antibacterial activity and intersecting with Pharmacology, Antibacterial agent, Thesaurus and In vivo.
He most often published in these fields:
- Microbiology (66.74%)
- Escherichia coli (21.81%)
- Drug resistance (15.64%)
What were the highlights of his more recent work (between 1984-1999)?
- Microbiology (66.74%)
- Antibacterial agent (8.59%)
- Antibacterial activity (11.67%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Microbiology, Antibacterial agent, Antibacterial activity, Antibiotics and Escherichia coli.
Susumu Mitsuhashi specializes in Microbiology, namely Norfloxacin.
His Antibacterial agent study integrates concerns from other disciplines, such as Klebsiella pneumoniae, DNA gyrase, Minimum inhibitory concentration, Piperacillin and Cefoperazone.
His Antibacterial activity research includes elements of In vitro, Intracellular, Thesaurus and Aztreonam.
His Escherichia coli research includes themes of Molecular biology and Molecular cloning.
Susumu Mitsuhashi has included themes like Plasmid and Carbapenem in his Pseudomonas aeruginosa study.
Between 1984 and 1999, his most popular works were:
- Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli. (193 citations)
- Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa. (152 citations)
- Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12. (135 citations)
In his most recent research, the most cited papers focused on:
- Bacteria
- Enzyme
- Antibiotics
Susumu Mitsuhashi mainly investigates Microbiology, Antibacterial agent, Norfloxacin, Staphylococcus aureus and DNA gyrase.
As part of his studies on Microbiology, Susumu Mitsuhashi often connects relevant areas like Antibacterial activity.
His Antibacterial agent research is multidisciplinary, relying on both Aminoglycoside and Klebsiella pneumoniae, Enterobacteriaceae, Escherichia coli.
In his work, Pseudomonadales and Plasmid is strongly intertwined with Pseudomonadaceae, which is a subfield of Norfloxacin.
His research integrates issues of Erythromycin, Antibiotics and Enterococcus in his study of Staphylococcus aureus.
His research investigates the connection between DNA gyrase and topics such as Citrobacter freundii that intersect with problems in Citrobacter.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
